Avalo Therapeutics, Inc. · NASDAQ:AVTX

Avoro Capital Advisors LLC's stake in Avalo Therapeutics, Inc. fell to 4.44% (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 14, 2026

Avoro Capital Advisors LLC's stake in Avalo Therapeutics, Inc. fell to 4.44%, 2,333,333 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).

Stake
4.44%
Shares
2,333,333
Intent
Passive
What changed
Fell below 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Avoro Capital Advisors LLC4.44%2,333,333
Behzad Aghazadeh4.44%2,333,333

Source

View original at SEC

Related